Assignee
POLARIS GROUP
CN·9 granted patents·4 pending applications·32 citations·filing 2004–2025
Top patents by PatentIndex Score
13 records- 0187US9333268B2Methods of treatment with arginine deiminasePOLARIS GROUP·Filed 2015·Granted May 10, 2016·10 cites·15 claims
- 0286US7323167B2Method of treatment with modified arginine deiminasePOLARIS GROUP·Filed 2004·Granted Jan 29, 2008·15 cites·11 claims
- 0376US9789170B2Arginine deiminase with reduced cross-reactivity toward ADI-PEG 20 antibodies for cancer treatmentPOLARIS GROUP·Filed 2015·Granted Oct 17, 2017·4 cites·27 claims
- 0473US7517882B2Protein kinase inhibitorsPOLARIS GROUP·Filed 2007·Granted Apr 14, 2009·3 cites·14 claims
- 0562US2024084282A1Modified arginine deiminasesPOLARIS GROUP·Filed 2023·Application pending·0 cites
- 0660US2025215414A1Combination cancer immunotherapies with arginine depletion agentsPOLARIS GROUP·Filed 2025·Application pending·0 cites
- 0758US11235037B2Arginine deiminase with reduced cross-reactivity toward ADI - PEG 20 antibodies for cancer treatmentPOLARIS GROUP·Filed 2014·Granted Feb 1, 2022·0 cites·20 claims
- 0858US2022105160A1Arginine deiminase with reduced cross-reactivity toward adi - peg 20 antibodies for cancer treatmentPOLARIS GROUP·Filed 2021·Application pending·0 cites
- 0957US12281339B2Combination cancer immunotherapies with arginine depletion agentsPOLARIS GROUP·Filed 2017·Granted Apr 22, 2025·0 cites·32 claims
- 1056US10525142B2Methods of treatment with arginine deiminasePOLARIS GROUP·Filed 2017·Granted Jan 7, 2020·0 cites·5 claims
- 1153US7785579B2Modified tumor necrosis factorPOLARIS GROUP·Filed 2006·Granted Aug 31, 2010·0 cites·20 claims
- 1253US2009247501A1Protein kinase inhibitorsPOLARIS GROUP·Filed 2009·Application pending·0 cites
- 1347US12370242B2Formulations of pegylated arginine deiminasePOLARIS GROUP·Filed 2017·Granted Jul 29, 2025·0 cites·20 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →